(Q24247146)

English

Rivastigmine for vascular cognitive impairment

scientific article (published 2004-04-19)

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Rivastigmine for vascular cognitive impairment (English)

0 references

main subject

cognitive dysfunction

1 reference

2

0 references

author name string

David Craig

series ordinal

1

0 references

publication date

19 April 2004

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Rivastigmine in subcortical vascular dementia: an open 22-month study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Rivastigmine in vascular dementia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Cholinesterase inhibitors and vascular dementia: another string to their bow?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Frontal-subcortical circuits and human behavior

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Donepezil for vascular cognitive impairment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Vascular cognitive impairment.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Clinical features of MRI-defined subcortical vascular disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

The Association between White Matter Lesions on Magnetic Resonance Imaging and Noncognitive Symptoms

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

21 January 2018

An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004744.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD004744.PUB2

0 references

PubMed ID

15846730

0 references

(Q24247146)

Rivastigmine for vascular cognitive impairment

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)